FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109806675> ?p ?o ?g. }

• W2109806675 endingPage "2177" @default.
• W2109806675 startingPage "2172" @default.
• W2109806675 abstract "Abstract Objectives: Recent evidence has shown that cyclooxygenase-2 (COX-2) inhibitors have potent antitumor activity in prostate cancer both in vitro and in vivo. However, human trials are absent. This study evaluated the efficacy of the COX-2 inhibitor celecoxib in prostate-specific antigen (PSA) recurrent prostate cancer after radiation therapy (X-ray therapy or XRT) or radical prostatectomy. Methods: Forty patients who had biochemical relapse after XRT or radical prostatectomy were treated with celecoxib 400 mg twice per day. Follow-up PSA levels were obtained at 3, 6, 12, and 18 months and subsequently every 6 months thereafter. Data were evaluated by calculating PSA doubling times and by calculating the slope of the curve of log(PSA) versus time to assess rate of PSA increase before and after celecoxib treatment for each patient. Results: Thirty-six of 40 (90%) patients had a slowing effect on their rate of PSA after 3 months, including 11 of 40 with a decline and 8 of 40 with stabilization of PSA. Short-term responses at 3 months continued at 6, 12, 18 months. Comparison of rate of PSA increase before versus after celecoxib treatment showed significant flattening of slope of log(PSA) versus time from pretreatment for each of the time points. There was no significant change in testosterone levels, suggesting an androgen-independent mechanism. Conclusions: COX-2 inhibitors may have an effect on serum PSA levels in patients with biochemical progression after XRT or radical prostatectomy. These results suggest that COX-2 inhibitors may help delay or prevent disease progression in these patients and thereby help extend the time until androgen deprivation therapy." @default.
• W2109806675 created "2016-06-24" @default.
• W2109806675 creator A5001098812 @default.
• W2109806675 creator A5002515600 @default.
• W2109806675 creator A5013954610 @default.
• W2109806675 creator A5026692318 @default.
• W2109806675 creator A5066292446 @default.
• W2109806675 creator A5073387299 @default.
• W2109806675 creator A5082025794 @default.
• W2109806675 date "2006-04-01" @default.
• W2109806675 modified "2023-09-29" @default.
• W2109806675 title "Phase II Trial of Celecoxib in Prostate-Specific Antigen Recurrent Prostate Cancer after Definitive Radiation Therapy or Radical Prostatectomy" @default.
• W2109806675 cites W165132104 @default.
• W2109806675 cites W1968083949 @default.
• W2109806675 cites W1973082494 @default.
• W2109806675 cites W1998394615 @default.
• W2109806675 cites W2001476006 @default.
• W2109806675 cites W2008811049 @default.
• W2109806675 cites W2011342311 @default.
• W2109806675 cites W2023520601 @default.
• W2109806675 cites W2024087814 @default.
• W2109806675 cites W2042902455 @default.
• W2109806675 cites W2049153532 @default.
• W2109806675 cites W2050310941 @default.
• W2109806675 cites W2050623189 @default.
• W2109806675 cites W2066735369 @default.
• W2109806675 cites W2156470937 @default.
• W2109806675 cites W2158131645 @default.
• W2109806675 cites W2158968701 @default.
• W2109806675 cites W2336169581 @default.
• W2109806675 cites W4246555452 @default.
• W2109806675 cites W4295773257 @default.
• W2109806675 doi "https://doi.org/10.1158/1078-0432.ccr-05-2067" @default.
• W2109806675 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16609031" @default.
• W2109806675 hasPublicationYear "2006" @default.
• W2109806675 type Work @default.
• W2109806675 sameAs 2109806675 @default.
• W2109806675 citedByCount "85" @default.
• W2109806675 countsByYear W21098066752012 @default.
• W2109806675 countsByYear W21098066752013 @default.
• W2109806675 countsByYear W21098066752014 @default.
• W2109806675 countsByYear W21098066752015 @default.
• W2109806675 countsByYear W21098066752016 @default.
• W2109806675 countsByYear W21098066752017 @default.
• W2109806675 countsByYear W21098066752018 @default.
• W2109806675 countsByYear W21098066752020 @default.
• W2109806675 countsByYear W21098066752021 @default.
• W2109806675 countsByYear W21098066752023 @default.
• W2109806675 crossrefType "journal-article" @default.
• W2109806675 hasAuthorship W2109806675A5001098812 @default.
• W2109806675 hasAuthorship W2109806675A5002515600 @default.
• W2109806675 hasAuthorship W2109806675A5013954610 @default.
• W2109806675 hasAuthorship W2109806675A5026692318 @default.
• W2109806675 hasAuthorship W2109806675A5066292446 @default.
• W2109806675 hasAuthorship W2109806675A5073387299 @default.
• W2109806675 hasAuthorship W2109806675A5082025794 @default.
• W2109806675 hasConcept C121608353 @default.
• W2109806675 hasConcept C126322002 @default.
• W2109806675 hasConcept C126894567 @default.
• W2109806675 hasConcept C143998085 @default.
• W2109806675 hasConcept C2776235491 @default.
• W2109806675 hasConcept C2776467144 @default.
• W2109806675 hasConcept C2777008409 @default.
• W2109806675 hasConcept C2779466945 @default.
• W2109806675 hasConcept C2780192828 @default.
• W2109806675 hasConcept C2781406297 @default.
• W2109806675 hasConcept C509974204 @default.
• W2109806675 hasConcept C71924100 @default.
• W2109806675 hasConceptScore W2109806675C121608353 @default.
• W2109806675 hasConceptScore W2109806675C126322002 @default.
• W2109806675 hasConceptScore W2109806675C126894567 @default.
• W2109806675 hasConceptScore W2109806675C143998085 @default.
• W2109806675 hasConceptScore W2109806675C2776235491 @default.
• W2109806675 hasConceptScore W2109806675C2776467144 @default.
• W2109806675 hasConceptScore W2109806675C2777008409 @default.
• W2109806675 hasConceptScore W2109806675C2779466945 @default.
• W2109806675 hasConceptScore W2109806675C2780192828 @default.
• W2109806675 hasConceptScore W2109806675C2781406297 @default.
• W2109806675 hasConceptScore W2109806675C509974204 @default.
• W2109806675 hasConceptScore W2109806675C71924100 @default.
• W2109806675 hasIssue "7" @default.
• W2109806675 hasLocation W21098066751 @default.
• W2109806675 hasLocation W21098066752 @default.
• W2109806675 hasOpenAccess W2109806675 @default.
• W2109806675 hasPrimaryLocation W21098066751 @default.
• W2109806675 hasRelatedWork W1181291060 @default.
• W2109806675 hasRelatedWork W1967410728 @default.
• W2109806675 hasRelatedWork W1968792361 @default.
• W2109806675 hasRelatedWork W1988513079 @default.
• W2109806675 hasRelatedWork W2109806675 @default.
• W2109806675 hasRelatedWork W3023689102 @default.
• W2109806675 hasRelatedWork W3150909901 @default.
• W2109806675 hasRelatedWork W4200381795 @default.
• W2109806675 hasRelatedWork W4241710403 @default.
• W2109806675 hasRelatedWork W4295773257 @default.
• W2109806675 hasVolume "12" @default.
• W2109806675 isParatext "false" @default.
• W2109806675 isRetracted "false" @default.

• next